Variant report
Variant | nsv914430 |
---|---|
Chromosome Location | chr22:21431181-21465780 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:869)
- CpG islands (count:0)
- Chromatin interactive region (count:63)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr22:21462458-21463637 | K562 | blood: | n/a | n/a |
2 | ARID3A | chr22:21452454-21452781 | K562 | blood: | n/a | n/a |
3 | ARID3A | chr22:21456951-21457433 | K562 | blood: | n/a | n/a |
4 | ATF1 | chr22:21447950-21448376 | K562 | blood: | n/a | n/a |
5 | ATF1 | chr22:21456948-21457439 | K562 | blood: | n/a | n/a |
6 | ATF1 | chr22:21454708-21455083 | K562 | blood: | n/a | n/a |
7 | ATF1 | chr22:21452396-21452913 | K562 | blood: | n/a | n/a |
8 | ATF1 | chr22:21459817-21459848 | K562 | blood: | n/a | n/a |
9 | ATF2 | chr22:21457002-21457536 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | ATF2 | chr22:21456997-21457475 | GM12878 | blood: | n/a | n/a |
11 | ATF2 | chr22:21457055-21457365 | GM12878 | blood: | n/a | n/a |
12 | ATF2 | chr22:21456969-21457507 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | ATF3 | chr22:21456887-21457665 | K562 | blood: | n/a | n/a |
14 | ATF3 | chr22:21456845-21457542 | K562 | blood: | n/a | n/a |
15 | BACH1 | chr22:21454361-21454398 | K562 | blood: | n/a | n/a |
16 | BACH1 | chr22:21462599-21463625 | K562 | blood: | n/a | n/a |
17 | BACH1 | chr22:21457063-21457536 | K562 | blood: | n/a | n/a |
18 | BACH1 | chr22:21457038-21457521 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | BACH1 | chr22:21462948-21463323 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | BCLAF1 | chr22:21457085-21457352 | GM12878 | blood: | n/a | n/a |
21 | BHLHE40 | chr22:21456903-21457481 | K562 | blood: | n/a | n/a |
22 | BHLHE40 | chr22:21452444-21452669 | K562 | blood: | n/a | n/a |
23 | BHLHE40 | chr22:21448023-21448312 | K562 | blood: | n/a | n/a |
24 | BRCA1 | chr22:21457031-21457337 | HepG2 | liver: | n/a | n/a |
25 | CBX3 | chr22:21452189-21452809 | K562 | blood: | n/a | n/a |
26 | CBX3 | chr22:21452219-21452829 | K562 | blood: | n/a | n/a |
27 | CBX3 | chr22:21456796-21457642 | K562 | blood: | n/a | n/a |
28 | CBX3 | chr22:21456904-21457465 | K562 | blood: | n/a | n/a |
29 | CCNT2 | chr22:21448114-21448229 | K562 | blood: | n/a | n/a |
30 | CCNT2 | chr22:21463069-21463100 | K562 | blood: | n/a | n/a |
31 | CCNT2 | chr22:21457069-21457499 | K562 | blood: | n/a | n/a |
32 | CEBPB | chr22:21447081-21447437 | K562 | blood: | n/a | chr22:21447262-21447275 |
33 | CEBPB | chr22:21460358-21460613 | HepG2 | liver: | n/a | chr22:21460477-21460488 |
34 | CEBPB | chr22:21444282-21444574 | A549 | lung: | n/a | n/a |
35 | CEBPB | chr22:21456952-21457490 | K562 | blood: | n/a | n/a |
36 | CEBPB | chr22:21457185-21457374 | HepG2 | liver: | n/a | n/a |
37 | CEBPB | chr22:21457134-21457455 | K562 | blood: | n/a | n/a |
38 | CEBPB | chr22:21444251-21444594 | K562 | blood: | n/a | n/a |
39 | CEBPB | chr22:21448007-21448208 | K562 | blood: | n/a | n/a |
40 | CEBPB | chr22:21457057-21457428 | H1-hESC | embryonic stem cell: | n/a | n/a |
41 | CEBPB | chr22:21460386-21460631 | K562 | blood: | n/a | chr22:21460477-21460488 |
42 | CEBPB | chr22:21454362-21454820 | MCF-7 | breast: | n/a | n/a |
43 | CEBPB | chr22:21447281-21447361 | H1-hESC | embryonic stem cell: | n/a | n/a |
44 | CEBPB | chr22:21447263-21447283 | Hela-S3 | cervix: | n/a | n/a |
45 | CEBPB | chr22:21460401-21460595 | A549 | lung: | n/a | chr22:21460477-21460488 |
46 | CEBPB | chr22:21444303-21444560 | IMR90 | lung: | n/a | n/a |
47 | CEBPB | chr22:21455111-21455178 | IMR90 | lung: | n/a | n/a |
48 | CEBPB | chr22:21455809-21456020 | IMR90 | lung: | n/a | n/a |
49 | CEBPB | chr22:21444259-21444588 | HepG2 | liver: | n/a | n/a |
50 | CEBPD | chr22:21447913-21448438 | K562 | blood: | n/a | n/a |
No data |
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr22:21445296..21448389-chr22:21448613..21450723,3 | K562 | blood: | |
2 | chr22:21382824..21385331-chr22:21454579..21456843,2 | MCF-7 | breast: | |
3 | chr22:21354959..21358124-chr22:21432393..21434030,3 | MCF-7 | breast: | |
4 | chr22:21272974..21274482-chr22:21453648..21456329,2 | MCF-7 | breast: | |
5 | chr22:21336242..21338866-chr22:21453255..21455106,2 | K562 | blood: | |
6 | chr22:21422859..21427453-chr22:21428543..21432939,6 | K562 | blood: | |
7 | chr22:21436101..21438308-chr22:21441491..21444463,2 | K562 | blood: | |
8 | chr22:21427307..21429775-chr22:21451659..21453902,2 | K562 | blood: | |
9 | chr22:21436101..21438308-chr22:21441491..21444463,2 | K562 | blood: | |
10 | chr22:21368793..21370356-chr22:21455117..21457274,2 | K562 | blood: | |
11 | chr22:21433522..21434065-chr22:21457136..21457771,2 | K562 | blood: | |
12 | chr22:21445053..21447572-chr22:21455705..21457230,2 | K562 | blood: | |
13 | chr22:21367571..21370293-chr22:21455185..21457274,3 | K562 | blood: | |
14 | chr22:21431214..21434190-chr22:21451363..21455420,3 | K562 | blood: | |
15 | chr22:21354638..21358198-chr22:21455223..21459884,5 | MCF-7 | breast: | |
16 | chr22:21440687..21442730-chr22:21443023..21445783,2 | K562 | blood: | |
17 | chr22:21398617..21400230-chr22:21452490..21454260,2 | K562 | blood: | |
18 | chr22:21394676..21396579-chr22:21432484..21435517,3 | K562 | blood: | |
19 | chr22:21447333..21449666-chr22:21453179..21455036,3 | K562 | blood: | |
20 | chr22:21419634..21422503-chr22:21431197..21433182,2 | K562 | blood: | |
21 | chr22:21427520..21431698-chr22:21432126..21436010,5 | K562 | blood: | |
22 | chr22:21427684..21429185-chr22:21441079..21443400,2 | K562 | blood: | |
23 | chr22:21419927..21422503-chr22:21429993..21432697,2 | K562 | blood: | |
24 | chr22:21334989..21337850-chr22:21456827..21459546,2 | K562 | blood: | |
25 | chr22:21448752..21453745-chr22:21453926..21457234,4 | MCF-7 | breast: | |
26 | chr22:21443711..21446922-chr22:21450828..21455317,4 | K562 | blood: | |
27 | chr22:21442941..21445162-chr22:21452590..21455058,2 | K562 | blood: | |
28 | chr22:21369240..21371713-chr22:21452349..21454093,2 | K562 | blood: | |
29 | chr22:21333668..21339906-chr22:21442541..21446559,5 | K562 | blood: | |
30 | chr22:21453029..21455213-chr22:21459459..21461681,2 | K562 | blood: | |
31 | chr22:21355227..21358354-chr22:21455605..21457626,3 | K562 | blood: | |
32 | chr22:21335711..21339145-chr22:21445059..21447466,3 | K562 | blood: | |
33 | chr22:21451265..21452805-chr22:21457465..21459683,2 | K562 | blood: | |
34 | chr22:21369251..21370907-chr22:21430130..21432937,2 | K562 | blood: | |
35 | chr22:21353014..21357310-chr22:21452902..21457294,6 | MCF-7 | breast: | |
36 | chr22:21445053..21447572-chr22:21455705..21457230,2 | K562 | blood: | |
37 | chr22:21270849..21272651-chr22:21455826..21458172,2 | MCF-7 | breast: | |
38 | chr22:21270165..21272988-chr22:21455197..21456764,2 | MCF-7 | breast: | |
39 | chr22:21440687..21442730-chr22:21443023..21445783,2 | K562 | blood: | |
40 | chr22:21427520..21431698-chr22:21432126..21436010,5 | K562 | blood: | |
41 | chr22:21431385..21433960-chr22:21448312..21450719,2 | MCF-7 | breast: | |
42 | chr22:21443711..21446922-chr22:21450828..21455317,4 | K562 | blood: | |
43 | chr22:21450378..21453014-chr22:21461236..21463100,2 | K562 | blood: | |
44 | chr22:21431385..21433960-chr22:21448312..21450719,2 | MCF-7 | breast: | |
45 | chr22:21450259..21452150-chr22:21453266..21455046,2 | K562 | blood: | |
46 | chr22:21355019..21358979-chr22:21433564..21435999,3 | K562 | blood: | |
47 | chr22:21314800..21316392-chr22:21454460..21457208,2 | K562 | blood: | |
48 | chr22:21445296..21448389-chr22:21448613..21450723,3 | K562 | blood: | |
49 | chr22:21450259..21452150-chr22:21453266..21455046,2 | K562 | blood: | |
50 | chr22:21355602..21358079-chr22:21461383..21463245,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
BCRP2 | TF binding region |
ENSG00000184436 | chromatin interactions |
ENSG00000183773 | chromatin interactions |
ENSG00000230513 | chromatin interactions |
ENSG00000169668 | chromatin interactions |
ENSG00000099949 | chromatin interactions |
ENSG00000249680 | chromatin interactions |
ENSG00000161149 | chromatin interactions |
ENSG00000206145 | chromatin interactions |
ENSG00000272829 | chromatin interactions |
ENSG00000099942 | chromatin interactions |
ENSG00000099957 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs439792 | chr22:21431181-21431182 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs112440982 | chr22:21431216-21431217 | Weak transcription Bivalent Enhancer Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs2308105 | chr22:21431217-21431218 | Weak transcription Bivalent Enhancer Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs150284151 | chr22:21431218-21431219 | Weak transcription Bivalent Enhancer Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs201652984 | chr22:21431221-21431222 | Weak transcription Bivalent Enhancer Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs76350452 | chr22:21431222-21431223 | Weak transcription Bivalent Enhancer Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs535778821 | chr22:21431246-21431247 | Weak transcription Bivalent Enhancer Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs141362907 | chr22:21431285-21431286 | Weak transcription Bivalent Enhancer Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs560541071 | chr22:21431286-21431287 | Weak transcription Bivalent Enhancer Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs12628413 | chr22:21431295-21431296 | Weak transcription Bivalent Enhancer Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs534330516 | chr22:21431344-21431345 | Weak transcription Bivalent Enhancer Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs557525308 | chr22:21431387-21431388 | Weak transcription Bivalent Enhancer Enhancers Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs373126463 | chr22:21431448-21431449 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs78051862 | chr22:21431471-21431472 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs536853016 | chr22:21431473-21431474 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs151329657 | chr22:21431476-21431477 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs573968956 | chr22:21431483-21431484 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs140423187 | chr22:21431484-21431485 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs544127632 | chr22:21431498-21431499 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs559706816 | chr22:21431542-21431543 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs554114535 | chr22:21431545-21431546 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs112406136 | chr22:21431562-21431563 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs114462221 | chr22:21431595-21431596 | Weak transcription Enhancers Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs71314761 | chr22:21431616-21431617 | Weak transcription Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs71314762 | chr22:21431627-21431628 | Weak transcription Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs539894661 | chr22:21431641-21431642 | Weak transcription Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs369711467 | chr22:21431666-21431667 | Weak transcription Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs6417765 | chr22:21431729-21431730 | Weak transcription Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs6417766 | chr22:21431744-21431745 | Weak transcription Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs6519750 | chr22:21431769-21431770 | Weak transcription Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs111632442 | chr22:21431782-21431783 | Weak transcription Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs73396433 | chr22:21431794-21431795 | Weak transcription Bivalent Enhancer Strong transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs549228435 | chr22:21431822-21431823 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs566039226 | chr22:21431831-21431832 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs150403255 | chr22:21431849-21431850 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs532017282 | chr22:21431893-21431894 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs111988699 | chr22:21431908-21431909 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs10571742 | chr22:21431929-21431930 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs111663980 | chr22:21431993-21431994 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs13057485 | chr22:21432002-21432003 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs13054227 | chr22:21432004-21432005 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs13057491 | chr22:21432019-21432020 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs11912969 | chr22:21432053-21432054 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs368238524 | chr22:21432073-21432074 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs373803645 | chr22:21432080-21432081 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs375083405 | chr22:21432106-21432107 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs556857641 | chr22:21432118-21432119 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs567441130 | chr22:21432126-21432127 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs547517725 | chr22:21432154-21432155 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs536466393 | chr22:21432168-21432169 | Weak transcription Strong transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Emanuel syndrome | 21549014 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Schizophrenia | 17504246 | CNVD |
Digeorge syndrome | 18033723 | CNVD |
22q11 deletion syndrome | 17034021 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
22q11 deletion syndrome | 16829213 | CNVD |
Autism | 22067053 | CNVD |
Autism | 19218893 | CNVD |
Biliary cancer | 22067053 | CNVD |
Congenital heart defect | 21390462 | CNVD |
Digeorge syndrome | 16617304 | CNVD |
Emanuel syndrome | 18184694 | CNVD |
Non-syndromic sensorineural hearing loss | 18184694 | CNVD |
Obsessive-compulsive disorder | 22067053 | CNVD |
Psychosis | 22067053 | CNVD |
Schizophrenia | 19415332 | CNVD |
Schizophrenia | 20587603 | CNVD |
Shprintzen syndrome | 19443537 | CNVD |
absent pulmonary valve syndrome | 16795129 | CNVD |
language delay | 22067053 | CNVD |
periventricular nodular heterotopia | 20648244 | CNVD |
renal disease | 17924346 | CNVD |
Schizophrenia | 20433910 | CNVD |
22q11 deletion syndrome | 17028864 | CNVD |
Schizophrenia | 16969581 | CNVD |
Non-syndromic sensorineural hearing loss | 17135275 | CNVD |
velo-cardio-facial syndrome | 17135275 | CNVD |
Digeorge syndrome | 18787571 | CNVD |
Autism | 18925931 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
22q11.2 microdeletion syndrome | 21547621 | CNVD |
Congenital heart defect | 21308838 | CNVD |
Digeorge syndrome | 16512914 | CNVD |
Digeorge syndrome | 20954168 | CNVD |
Nuchal translucency | 21837766 | CNVD |
Right aortic arch in the fetus | 17066500 | CNVD |
Shprintzen syndrome | 17117043 | CNVD |
Tetralogy of fallot | 17405110 | CNVD |
Velocardiofacial syndrome | 20140301 | CNVD |
Velocardiofacial syndrome | 16512914 | CNVD |
bone mass and metabolism | 20516202 | CNVD |
choanal atresia | 18209138 | CNVD |
extracardiac malformations | 17086578 | CNVD |
fetal heart defects | 21308838 | CNVD |
parathyroid gland dysfunction | 16793949 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
velopharyngeal insufficiency | 19620585 | CNVD |
Prader-willi syndrome | 20942916 | CNVD |
22q11 deletion syndrome | 17653112 | CNVD |
Chronic myelomonocytic leukemia | 16760666 | CNVD |
Non-syndromic sensorineural hearing loss | 16829213 | CNVD |
Non-syndromic sensorineural hearing loss | 16760666 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cat eye syndrome | 21549014 | CNVD |
Digeorge syndrome | 21549014 | CNVD |
22q11.2 microdeletion syndrome | 22051516 | CNVD |
22q11.2 microdeletion syndrome | 18483005 | CNVD |
22q11.2 microdeletion syndrome | 19565140 | CNVD |
22q11.2 microdeletion syndrome | 20396437 | CNVD |
22q11.2 microdeletion syndrome | 21390462 | CNVD |
22q11.2 microdeletion syndrome | 21573985 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 20970697 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Congenital heart defect | 21257016 | CNVD |
Developmental delay | 18414209 | CNVD |
DiGeorge-Velo cardiofacial | 19284877 | CNVD |
Epilepsy | 20970697 | CNVD |
Heart disease | 20551144 | CNVD |
Hughes'' syndrome | 16595601 | CNVD |
Mental retardation | 18414209 | CNVD |
Okamoto syndrome | 19046188 | CNVD |
Primary immunodeficiency | 22566803 | CNVD |
Schizophrenia | 20877625 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 21956041 | CNVD |
Schizophrenia | 20970697 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Velocardiofacial syndrome | 17556857 | CNVD |
Velocardiofacial syndrome | 20206275 | CNVD |
Velocardiofacial syndrome | 20970697 | CNVD |
delayed speech development | 21274400 | CNVD |
velo-cardio-facial syndrome | 16511839 | CNVD |
velo-cardio-facial syndrome | 21763005 | CNVD |
22q11.2 microdeletion syndrome | 18799940 | CNVD |
Digeorge syndrome | 20877625 | CNVD |
22q11.2 microdeletion syndrome | 18923514 | CNVD |
Congenital heart defect | 22185286 | CNVD |
DiGeorge-Velo cardiofacial | 16773131 | CNVD |
Digeorge syndrome | 20186050 | CNVD |
velo-cardio-facial conotruncal-face syndrome | 20186050 | CNVD |
22q11.2 microdeletion syndrome | 22116936 | CNVD |
Disorders of sex development | 22290220 | CNVD |
22q11.2 duplication syndrome | 18923514 | CNVD |
Autism | 22095694 | CNVD |
Mental retardation | 19951919 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Mental retardation | 16773131 | CNVD |
22q11.2 microdeletion syndrome | 22395003 | CNVD |
22q11.2 microdeletion syndrome | 18691436 | CNVD |
22q11.2 microdeletion syndrome | 18053182 | CNVD |
22q11.2 microdeletion syndrome | 18324686 | CNVD |
22q11.2 microdeletion syndrome | 20074913 | CNVD |
Congenital heart defect | 20802965 | CNVD |
Congenital heart defect | 21134246 | CNVD |
DiGeorge syndrome | 19040613 | CNVD |
DiGeorge-Velo cardiofacial | 18179902 | CNVD |
Digeorge syndrome | 18172682 | CNVD |
Digeorge syndrome | 22470819 | CNVD |
Digeorge syndrome | 21364285 | CNVD |
Neuroendocrine carcinoma | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20069674 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Tetralogy of fallot | 19144126 | CNVD |
Velo-cardio-facial syndrome | 21364285 | CNVD |
Velocardiofacial syndrome | 18788013 | CNVD |
cardiac malformation | 20573211 | CNVD |
cardiac malformation | 18172682 | CNVD |
velo-cardio-facial syndrome | 18636631 | CNVD |
Schizophrenia | 21822266 | CNVD |
synaptic plasticity | 21368174 | CNVD |
Schizophrenia | 18043741 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Autism | 19046189 | CNVD |
DiGeorge-Velo cardiofacial | 19047251 | CNVD |
Hypernasal speech | 21968682 | CNVD |
Mental retardation | 17339581 | CNVD |
diverse phenotype | 16760730 | CNVD |
Mental retardation | 20152051 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 19521722 | CNVD |
Digeorge syndrome | 19521722 | CNVD |
Autism | 19955444 | CNVD |
Schizophrenia | 19955444 | CNVD |
Mental retardation | 17124404 | CNVD |
Tourette syndrome | 20069037 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Emphysema | 19352772 | CNVD |
Schizophrenia | 17160897 | CNVD |
Cancer | 17160897 | CNVD |
Neuropsychiatric disorder | 20069037 | CNVD |
DiGeorge-Velo cardiofacial | 17597781 | CNVD |
Digeorge syndrome | 17576883 | CNVD |
Schizophrenia | 18806272 | CNVD |
Schizophrenia | 18990708 | CNVD |
Velocardiofacial syndrome | 17576883 | CNVD |
Schizophrenia | 20075378 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
22q11.2 deletion syndrome | 22563040 | CNVD |
Disease | 21346257 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Developmental delay | 21147756 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
Cancer | 20164919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Prader-willi syndrome | 20588305 | CNVD |
T-cell acute lymphoblastic leukemia | 21980252 | CNVD |
22q11.22 microdeletion syndrome | 19193630 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Schizophrenia | 20967226 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:21427600-21435600 | Strong transcription | Right Atrium | heart |
2 | chr22:21428600-21434800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr22:21428800-21435000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr22:21429200-21431200 | Weak transcription | HSMM | muscle |
5 | chr22:21429600-21431400 | Enhancers | Placenta | Placenta |
6 | chr22:21429800-21431200 | Enhancers | Fetal Muscle Trunk | muscle |
7 | chr22:21430600-21431600 | Enhancers | Fetal Muscle Leg | muscle |
8 | chr22:21431000-21431200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr22:21431000-21431200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr22:21431000-21431200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr22:21431200-21431400 | Enhancers | HSMM | muscle |
12 | chr22:21431200-21431800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
13 | chr22:21431200-21433000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr22:21431400-21431600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr22:21431600-21432600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr22:21431800-21434800 | Weak transcription | Spleen | Spleen |
17 | chr22:21432600-21433800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr22:21433000-21433800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
19 | chr22:21433000-21433800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
20 | chr22:21434800-21435000 | Bivalent Enhancer | Right Ventricle | heart |
21 | chr22:21434800-21435200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
22 | chr22:21434800-21435600 | Enhancers | Spleen | Spleen |
23 | chr22:21435000-21435200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
24 | chr22:21435200-21435400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
25 | chr22:21435600-21457000 | Weak transcription | Right Atrium | heart |
26 | chr22:21436600-21437000 | Enhancers | Muscle Satellite Cultured Cells | -- |
27 | chr22:21447000-21449600 | Enhancers | K562 | blood |
28 | chr22:21447000-21449800 | Enhancers | Fetal Intestine Small | intestine |
29 | chr22:21447200-21447400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
30 | chr22:21447200-21448200 | Enhancers | Pancreas | Pancrea |
31 | chr22:21447400-21447600 | Enhancers | Fetal Intestine Large | intestine |
32 | chr22:21447600-21452400 | Weak transcription | Fetal Intestine Large | intestine |
33 | chr22:21447800-21448400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
34 | chr22:21448400-21449000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
35 | chr22:21448400-21454800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
36 | chr22:21449800-21452400 | Weak transcription | Fetal Intestine Small | intestine |
37 | chr22:21452400-21452600 | Enhancers | Fetal Intestine Large | intestine |
38 | chr22:21452400-21452600 | Bivalent Enhancer | K562 | blood |
39 | chr22:21452400-21452800 | ZNF genes & repeats | Fetal Intestine Small | intestine |
40 | chr22:21452600-21453000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
41 | chr22:21452800-21454200 | Weak transcription | Fetal Intestine Small | intestine |
42 | chr22:21453000-21457200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
43 | chr22:21453600-21457000 | Enhancers | Hela-S3 | cervix |
44 | chr22:21454400-21454600 | Bivalent Enhancer | Osteobl | bone |
45 | chr22:21454400-21455200 | Enhancers | Placenta | Placenta |
46 | chr22:21454400-21455400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
47 | chr22:21454400-21457400 | Enhancers | NHDF-Ad | bronchial |
48 | chr22:21454400-21457600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
49 | chr22:21454400-21457600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
50 | chr22:21454400-21457600 | Enhancers | NHLF | lung |